Andreas Schaaf is the founder of Eleva. Eleva has raised $66M in total funding. Latest round: Series A. Backed by Zukunftsfonds Heilbronn.
Andreas Schaaf is the CSO of Eleva, a company based in Freiburg, Germany. Eleva manufactures superior biologics and utilizes a moss-based platform to produce novel drugs. In January 2021, Eleva secured up to EUR 60 million in funding from Zukunftsfonds Heilbronn to advance one of its drug candidates, CPV-101.
Full founder directory · Investor directory · Company funding database · Fundraising library